Shares of Alexion (ALXN +8.7%) pop after issuing upward guidance, and announcing it plans to...

|About: Alexion Pharmaceuticals, ... (ALXN)|By:, SA News Editor

Shares of Alexion (ALXN +8.7%) pop after issuing upward guidance, and announcing it plans to launch its Soliris treatment for patients with aHUS in Q4. (PR)